ArticleScientific reports2026
Silver nanoparticles synthesized from Sempervivum tectorum leaf extract show antibacterial activity against canine Staphylococcus pseudintermedius.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite developing a broad spectrum of antibiotics, pathogenic bacteria remain the primary health concern. The emergence of drug-resistant strains increased therapeutic failure and mortality. The researchers are currently focusing on developing nanotechnology-based medicines to combat resistance. Our study focuses on the antimicrobial characteristics of plant-mediated silver nanoparticles (Ag NPs). The AgNPs were green synthesized (using thermal treatment) to reduce silver nitrate solution (AgNO3) using Sempervivum (S.) tectorum L. plant ethanolic aqueous extract. They were found to be broad-spectrum antimicrobial agents against two Staphylococcus (S.) pseudintermedius strains. We investigated AgNPs’ antibacterial activity with time-kill curves, MIC, MBC, and well diffusion. The tests also showed a high activity of the particles against S pseudintermedius, with the minimum inhibitory concentrations ranging between 18.6 and 90.13 µg/ml. The prepared AgNPs were then characterized using scanning UV-visible spectroscopy, X-ray diffraction, and transmission electronic microscopy (TEM) to study their morphology and crystallinity. Two distinctive absorption peaks of AgNP samples were observed at 474 nm and 487 nm for leaf extract samples, with a spherical shape with face-centered cubic (FCC) crystalline structure and diameter range between 10 and 60 nm, respectively. The impact was significantly more significant when the NPs were less than 30 nm in size. The study revealed that an ethanolic aqueous extract of S. tectorum L. may effectively reduce and stabilize silver nanoparticles (AgNPs) of various sizes, depending on the solvent concentration. The AgNPs have shown efficacy in both suppressing and eradicating microorganisms. The activity of AgNPs may be facilitated by a dual approach involving several processes of nanoparticles, such as the formation of reactive oxygen species and the presence of phytocompounds such as phenolics and proanthocyanidins bound to the nanoparticle surface. Nanotechnology-based therapies play a crucial role in treating microbial illnesses in veterinary medicine. Significant areas of research on nanoparticles (NPs) could include studying the synergistic interactions between Ag NPs and antibiotics, doing toxicity profiling, examining stability, and investigating bioavailability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.